相关实验视频
Updated: Jul 6, 2025
09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.7K
泰罗菲班对大血管闭塞中风的作用因病因和功能而改变
Chang Liu1, Fengli Li2, Liyuan Chen1
1Department of Neurology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Annals of clinical and translational neurology
|December 29, 2023
概括
功能会影响大血管封闭性中风中的提罗非班的有效性. 在患有正常功能和大动脉动脉硬化症的患者中,蒂罗菲班改善了结果,但在患有功能障碍的患者中没有改善.
科学领域:
- 神经学 神经学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 功能会影响中风的结果和药物的药理动力学.
- 泰罗菲班在急性缺血性中风与大血管封闭 (LVO) 的疗效和安全性可能会受到功能障碍的影响.
研究的目的:
- 为了研究功能在静脉静脉治疗前 (EVT) 对于LVO.急性缺血性中风患者的静脉注射蒂罗菲班的疗效和安全性中的作用.
主要方法:
- 对RESCUE-BT试验的特异分析.
- 主要结局:90天后的功能独立 (修改的兰金尺度0-2).
- 主要安全结局:症状性内出血 (sICH).
主要成果:
- 降低EGFR在心血管血栓性中风 (CE) 患者中更为常见.
- 在大动脉动脉样硬化 (LAA) 患者中,功能正常,蒂罗菲班改善了功能独立性 (41.67%与59.80%,p=0.003).
- 蒂罗菲班在LVO患者中没有改善功能障碍的结果,并且在非LAA患者中增加了SICH风险.
结论:
- 在给接受EVT的LVO患者注射静脉罗非班之前,评估功能至关重要.
- 脏状况显著改变了罗非班在急性缺血性中风管理中的益处风险概况.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
95
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:11Renal Failure: Dose Adjustments
94
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
94
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
236
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
236
01:16Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702